# Exploration the Mechanism of Ba-Duan-Jin Therapy in the Management of Fibromyalgia

> **NCT03890133** · NA · COMPLETED · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **BEHAVIORAL:** Ba-Duan-Jin
- **DRUG:** Pregabalin capsule

## Key facts

- **NCT ID:** NCT03890133
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03890133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03890133, "Exploration the Mechanism of Ba-Duan-Jin Therapy in the Management of Fibromyalgia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03890133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*